THE SENATE

THE TWENTY-EIGHTH LEGISLATURE

REGULAR SESSION OF 2016

 

COMMITTEE ON WAYS AND MEANS

Senator Jill N. Tokuda, Chair

Senator Donovan M. Dela Cruz, Vice Chair

 

NOTICE OF DECISION MAKING

 

 

DATE:

Tuesday, February 23, 2016

TIME:

9:50 a.m.

PLACE:

Conference Room 211

State Capitol

415 South Beretania Street

 

A G E N D A

 

The following measure(s) were previously heard in their respective committees:

 

SB 2392, SD1

      (SSCR2361)

      Status & Testimony

RELATING TO OPIOID ANTAGONISTS.

Creates immunity for health care professionals and pharmacists who prescribe, dispense, or administer an opioid antagonist such as naloxone hydrochloride to assist an individual at risk of experiencing an opioid-related drug overdose or to a harm reduction organization.  Creates immunity for first responders, harm reduction organizations, and individuals who administer opioid antagonists to persons believed to be suffering an opioid-related drug overdose.  Authorizes emergency personnel to administer an opioid antagonist.  Requires medicaid coverage for opioid antagonists for outpatient use.  Authorizes certain persons or organizations acting under standing orders issued by a licensed health care professional to store opioid antagonists without being subject to the Hawaii Food, Drug, and Cosmetic Act, except the portion regarding the storage of wholesale prescription drugs, and to distribute opioid antagonists without charge or compensation.  (SD1)

 

CPH/JDL, WAM

SB 2240

      (SSCR2098)

      Status & Testimony

MAKING AN APPROPRIATION TO THE DEPARTMENT OF HEALTH TO REESTABLISH A VECTOR CONTROL BRANCH.

Makes an appropriation to the department of health to hire more vector control employees and reestablish a vector control branch.

 

CPH, WAM

SB 2687

      (SSCR2129)

      Status & Testimony

RELATING TO CANCER.

Creates the colorectal cancer screening and awareness program within the department of health and appropriates funds for the program.

 

CPH, WAM

SB 2317, SD1

      (SSCR2422)

      Status & Testimony

RELATING TO HEALTH.

Appropriates funds to the department of health to conduct child death reviews and implement a program to perform maternal death reviews.  Requires the department of health to submit an annual report to the legislature relating to child and maternal deaths and death reviews in the State.  Requires any person, hospital, sanitorium, nursing or rest home, or other similar medical facility to provide information or other materials relating to the condition and treatment of any person to the maternal and perinatal mortality study committee of the Hawaii Medical Association, any in-hospital staff committee, or the Department of Health for studies to reduce morbidity or mortality.  (SD1)

 

CPH, WAM

SB 2007, SD1

      (SSCR2242)

      Status & Testimony

RELATING TO STATE COUNCIL ON MENTAL HEALTH.

Amends the membership of the State Council on Mental Health, defines quorum for the Council, and specifies number of votes required to constitute valid acts of the Council.  Designates the State Council on Mental Health within the department of health for administrative purposes.  (SD1)

 

CPH, WAM

SB 2008, SD1

      (SSCR2241)

      Status & Testimony

RELATING TO SERVICE AREA BOARDS.

Amends statutory provisions relating to quorum and voting requirements for service area boards on mental health and substance abuse.  Designates service area boards on mental health and substance abuse within the department of health for administrative purposes.  (SD1)

 

CPH, WAM

SB 2887, SD1

      (SSCR2220)

      Status & Testimony

RELATING TO DEVELOPMENTAL DISABILITIES.

Amends the definition of "developmental disabilities" in section 333F-1, Hawaii Revised Statutes, to include children from birth to age 9 who have a substantial developmental delay or specific congenital or acquired condition and without services and supports, have a high probability of meeting criteria for developmental disabilities later in life.  (SD1)

 

CPH, WAM

SB 2213, SD1

      (SSCR2205)

      Status & Testimony

RELATING TO THE NURSING FACILITY SUSTAINABILITY PROGRAM.

Continues the nursing facility sustainability program for one additional year.  Appropriates funds out of the nursing facility sustainability program special fund for fiscal year 2016-2017.  (SD1)

 

HMS/CPH, WAM

SB 2330, SD1

      (SSCR2147)

      Status & Testimony

RELATING TO THE HOSPITAL SUSTAINABILITY PROGRAM.

Continues the hospital sustainability program for one year.  Appropriates funds out of the hospital sustainability program special fund for fiscal year 2016-2017.  Amends various reimbursement rates under the program to certain private hospitals through medicaid managed care health plans, and uncompensated care and disproportionate share hospital payments.  (SD1)

 

CPH/HMS, WAM

SB 2076, SD1

      (SSCR2262)

      Status & Testimony

RELATING TO HEALTH CARE.

Establishes a durable medical equipment supplier license program for suppliers of durable medical equipment, prosthetics, orthotics, and related supplies through the office of health care assurance.  Allows license fees to be deposited into the office of health care assurance special fund.  Amends the cap on amounts of the health care assurance special fund that may be used per fiscal year.  Amends the balance of the office of health care assurance special fund above which moneys are deposited into the general fund.  (SD1)

 

CPH, WAM

SB 2319, SD1

      (SSCR2327)

      Status & Testimony

RELATING TO INSURANCE.

Requires all insurers in the State, including health benefits plans under chapter 87A, Hawaii Revised Statutes, and medicaid managed care programs, to cover reimbursement for contraceptive supplies intended to last for up to a twelve-month period for an insured.  (SD1)

 

CPH, WAM

SB 2323, SD1

      (SSCR2112)

      Status & Testimony

RELATING TO INSURANCE COVERAGE OF HEALTH SCREENINGS.

Ensures insurance coverage for sexually transmitted disease testing in accordance with national professional guidelines, such as those of the United States Preventive Services Task Force and the federal Centers for Disease Control and Prevention.  Applies to health insurance policies, contracts, and plans issued or renewed after January 1, 2017.  (SD1)

 

CPH, WAM

SB 2668, SD1

      (SSCR2468)

      Status & Testimony

RELATING TO INSURANCE.

Specifies disclosure requirements for health care providers, health care facilities, and hospitals who are nonparticipating providers in a patient's health care plan.  Specifies the amount a nonparticipating provider may bill for services performed without prior or subsequent authorization from a patient's health care plan.  Specifies an insured shall not be liable to a health care provider for any sums owed by an insurer.  Specifies that an insured who receives emergency services from a nonparticipating provider shall not incur greater out-of-pocket costs for the emergency services than the insured would have incurred with a participating provider.  Effective 7/1/2050.  (SD1)

 

CPH/JDL, WAM

SB 2395, SD1

      (SSCR2287)

      Status & Testimony

RELATING TO TELEHEALTH.

Requires the State's medicaid managed care and fee-for-service programs to cover services provided through telehealth.  Specifies that any telehealth services provided shall be consistent with all federal and state privacy, security, and confidentiality laws.  Specifies medical professional liability insurance policy requirements with regard to telehealth coverage.  Clarifies that reimbursement for services provided through telehealth shall be equivalent to reimbursement for the same services provided via face-to-face contact between a health care provider and a patient.  Requires written disclosure of coverages and benefits associated with telehealth services.  Ensures telehealth encompasses store and forward technologies, remote monitoring, live consultation, and mobile health.  Ensures telehealth is covered when originating in a patient's home and other non-medical environments.  Clarifies requirements for physicians and out-of-state physicians to establish a physician-patient relationship via telehealth.  Ensures reimbursement requirements for telehealth services apply to all health benefits plans under chapter 87A, Hawaii Revised Statutes.  Makes other conforming amendments related to telehealth.  Effective 7/1/2050.  (SD1)

 

CPH/HMS, WAM

SB 2667

      (SSCR2384)

      Status & Testimony

RELATING TO INSURANCE.

Requires health insurers to promptly pay clean claims for services and repeals the exemption of medicaid claims from the clean claims definition.

 

CPH/HMS, WAM

SB 2539, SD1

      (SSCR2111)

      Status & Testimony

RELATING TO THE SPECIAL ACTION TEAM FOR THE HAWAII STATE HOSPITAL.

Establishes a temporary special action team for the Hawaii state hospital to address the capacity and census issues at the hospital and the development there of a new forensic facility ready for occupancy by June 30, 2019.  Appropriates $50,000 in general funds for the team.  (SD1)

 

CPH, WAM

 

 

 

 

Decision making meeting only, no oral testimony will be accepted.

 

Persons wishing to submit written testimony may do so up to 24 hours prior to the hearing.

 

Click here to submit written testimony to the Senate Committee on Ways and Means.

 

FOR AMENDED NOTICES:  Measures that have been deleted are stricken through and measures that have been added are underscored.  If a measure is both underscored and stricken through, that measure has been deleted from the agenda.

 

If you require auxiliary aids or services to participate in the public hearing process (i.e. ASL or foreign language interpreter, or wheelchair accessibility), please contact the committee clerk at least 24 hours prior to the hearing so that arrangements can be made.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808) 586-6800.

 

 

 

 

_____________________________________

Senator Jill N. Tokuda

Chair